NOVAVAX INC - COM (NVAX)

CUSIP: 670002104

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
156,744,426
Share change
-5,786,883
Total reported value
$294,684,409
Put/Call ratio
106%
Price per share
$1.88
Number of holders
155
Value change
-$5,948,676
Number of buys
55
Number of sells
61

Quarterly Holders Quick Answers

What is CUSIP 670002104?
CUSIP 670002104 identifies NVAX - NOVAVAX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVAVAX INC - COM (NVAX) as of Q3 2018

As of 30 Sep 2018, NOVAVAX INC - COM (NVAX) was held by 155 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 156,744,426 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, BB BIOTECH AG, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and FMR LLC. This page lists 155 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.